|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EMBRYONIC STEM CELLS/INDUCED PLURIPOTENT STEM CELLS |
aRuth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel;
bRambam Medical Center, Haifa, Israel
Key Words. Human embryonic stem cell-derived cardiomyocytes • 1,4,5-Inositol trisphosphate • Angiotensin-II • Endothelin-1 • Intracellular Ca2+ transient • Contraction
Correspondence: Correspondence: Ofer Binah, Ph.D., Rappaport Institute, P.O. Box 9697, Haifa 31096, Israel. Telephone: 972-4-8295262; Fax: 972-4-8513919; e-mail: binah{at}tx.technion.ac.il; or Joseph Itskovitz-Eldor, M.D., Ph.D., Rambam Medical Center, Haifa 31096, Israel. Telephone: 972-4-8542536; e-mail: itskovitz{at}rambam.health.gov.il
Received on August 12, 2008;
accepted for publication on September 11, 2008.
First published online in STEM CELLS EXPRESS September 25, 2008.
On the basis of previous findings suggesting that in human embryonic stem cell-derived cardiomyocytes (hESC-CM) the sarcoplasmic reticulum Ca2+-induced release of calcium machinery is either absent or immature, in the present study we tested the hypothesis that hESC-CM contain fully functional 1,4,5-inositol trisphosphate (1,4,5-IP3)-operated intracellular Ca2+ ([Ca2+]i) stores that can be mobilized upon appropriate physiological stimuli. To test this hypothesis we investigated the effects of angiotensin-II (AT-II) and endothelin-1 (ET-1), which activate the 1,4,5-IP3 pathway, on [Ca2+]i transients and contractions in beating clusters of hESC-CM. Our major findings were that in paced hESC-CM both AT-II and ET-1 (10–9 to 10–7 M) increased the contraction amplitude and the maximal rates of contraction and relaxation. In addition, AT-II (10–9 to 10–7 M) increased the [Ca2+]i transient amplitude. The involvement of 1,4,5-IP3-dependent intracellular Ca2+ release in the inotropic effect of AT-II was supported by the findings that (a) hESC-CM express AT-II, ET-1, and 1,4,5-IP3 receptors determined by immunofluorescence staining, and (b) the effects of AT-II were blocked by 2 µM 2-aminoethoxyphenyl borate (a 1,4,5-IP3 receptor blocker) and U73122
[GenBank]
(a phospholipase C blocker). In conclusion, these findings demonstrate for the first time that hESC-CM exhibit functional AT-II and ET-1 signaling pathways, as well as 1,4,5-IP3-operated releasable Ca2+ stores.
Disclosure of potential conflicts of interest is found at the end of this article.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |